Concepedia

Adel Samson

AS

Statistics

Publications

24

Citations

1K

H-Index

18

Active since

2016

Affiliations

University of Leeds(Current)

St James's University Hospital

Institute of Cancer Research

Mayo Clinic

University of Surrey

Adel Samson is an author at University of Leeds specializing in oncology, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2016–2025

24

Publications

24

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade

Adel Samson, Karen J. Scott, David J. Taggart et al. · Science Translational Medicine · 2018 · 377 citations · Full text

, , +17

Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer

Adel Samson, Matthew Bentham, Karen J. Scott et al. · Gut · 2016 · 81 citations · Full text

, , +17

APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy

Christopher B. Driscoll, Matthew Schuelke, Timothy Kottke et al. · Nature Communications · 2020 · 77 citations · Full text

, , +17

Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition

Victoria A. Jennings, Gina B. Scott, Ailsa M.S. Rose et al. · Molecular Therapy · 2019 · 57 citations · Full text

, , +17

Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients

Adel Samson, Emma J. West, Jonathan Carmichael et al. · Cancer Immunology Research · 2022 · 50 citations · Full text

, , +17

1–5 of 24